| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO And CFO
1 company
Patel Snehal is a CEO And CFO at Greenwich LifeSciences, Inc.. Recent SEC Form 4 filings include 10 buys and 0 sells.
Estimated insider holdings value: $80.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2023 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 1,000 | $18.68 | $18,680.00 | - | -41.5% | -55.1% | |
| Jan 27, 2023 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 2,000 | $19.35 | $38,700.00 | - | -46.5% | -54.9% | |
| Jan 20, 2023 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 1,500 | $17.37 | $26,055.00 | - | -37.9% | -47.7% | |
| Jan 6, 2023 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 1,500 | $15.18 | $22,770.00 | - | -11.2% | -34.4% | |
| Dec 29, 2022 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 4,000 | $15.19 | $60,760.00 | +0.1% | -7.6% | -31.1% | |
| Dec 16, 2022 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 1,000 | $13.01 | $13,010.00 | - | +2.2% | -15.3% | |
| Dec 9, 2022 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 2,000 | $13.11 | $26,220.00 | - | -0.6% | -9.2% | |
| Dec 2, 2022 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 1,000 | $13.84 | $13,840.00 | - | +6.5% | -15.0% | |
| Nov 2, 2022 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 2,000 | $8.79 | $17,580.00 | - | +125.2% | -1.9% | |
| Oct 14, 2022 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 3,000 | $9.75 | $29,250.00 | +0.1% | +64.7% | -12.4% |